Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer

Journal of Clinical Oncology

Volumn 30, Issue 36, 2012, Pages 4493-4500

  McLaughlin, John M ^a   Anderson, Roger T ^b   Ferketich, Amy K ^a   Seiber, Eric E ^a   Balkrishnan, Rajesh ^c   Paskett, Electra D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; DATA BASE; FEMALE; FOLLOW UP; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAID; PRIORITY JOURNAL; THERAPY DELAY; TUMOR BIOPSY;

BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MAMMOGRAPHY; MEDICAID; MIDDLE AGED; NORTH CAROLINA; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS;

EID: 84871804207     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.39.7695     Document Type: Article

References (57)

1. Richards MA, Westcombe AM, Love SB, et al: Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 353:1119-1126, 1999
2. Afzelius P, Zedeler K, Sommer H, et al: Patient's and doctor's delay in primary breast cancer: Prognostic implications. Acta Oncol 33:345-351, 1994
3. Sainsbury R, Johnston C, Haward B: Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis. Lancet 353:1132-1135, 1999
4. Delgado DJ, Lin WY, Coffey M: The role of Hispanic race/ethnicity and poverty in breast cancer survival. P R Health Sci J 14:103-116, 1995
5. Redondo M, Rodrigo I, Pereda T, et al: Prognostic implications of emergency admission and delays in patients with breast cancer. Support Care Cancer 17:595-599, 2009
6. Smith ER, Adams SA, Das IP, et al: Breast cancer survival among economically disadvantaged women: The influences of delayed diagnosis and treatment on mortality. Cancer Epidemiol Biomarkers Prev 17:2882-2890, 2008
7. Ganry O, Peng J, Dubreuil A: Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen 11:28-31, 2004
8. Olivotto IA, Gomi A, Bancej C, et al: Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94:2143-2150, 2002
9. Alderson MR, Hamlin I, Staunton MD: The relative significance of prognostic factors in breast carcinoma. Br J Cancer 25:646-656, 1971
10. Bloom HJ: The influence of delay on the natural history and prognosis of breast cancer: A study of cases followed for five to twenty years. Br J Cancer 19:228-262, 1965
11. Brinkley D, Haybittle JL: A 15-year follow-up study of patients treated for carcinoma of the breast. Br J Radiol 41:215-221, 1968
12. Dennis CR, Gardner B, Lim B: Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer 35:714-720, 1975
13. Devitt JE: The clinical stages of breast cancer: What do they mean? Can Med Assoc J 97:1257-1262, 1967
14. Elwood JM, Moorehead WP: Delay in diagnosis and long-term survival in breast cancer. BMJ 280:1291-1294, 1980
15. Humphrey LJ, Swerdlow M: Factors influencing the survival of patients with carcinoma of the breast. Am J Surg 106:440-444, 1963
16. Robbins GF, Bross I: The significance of delay in relation to prognosis of patients with primary operable breast cancer. Cancer 10:338-344, 1957
17. Sheridan B, Fleming J, Atkinson L, et al: The effects of delay in treatment of survival rates in carcinoma of the breast. Med J Aust 1:262-267, 1971
18. Blackman DJ, Masi CM: Racial and ethnic disparities in breast cancer mortality: Are we doing enough to address the root causes? J Clin Oncol 24:2170-2178, 2006
19. Gregorio DI, Cummings KM, Michalek A: Delay, stage of disease, and survival among white and black women with breast cancer. Am J Public Health 73:590-593, 1983
20. Hébert-Croteau N, Freeman CR, Latreille J, et al: A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat 88:187-196, 2004
21. Hershman D, McBride R, Jacobson JS, et al: Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23:6639-6646, 2005
22. Hershman DL, Unger JM, Barlow WE, et al: Treatment quality and outcomes of African American versus white breast cancer patients: Retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 27:2157-2162, 2009
23. Hershman DL, Wang X, McBride R, et al: Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65:1353-1360, 2006
24. Hershman DL, Wang X, McBride R, et al: Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 99:313-321, 2006
25. Lohrisch C, Paltiel C, Gelmon K, et al: Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 24:4888-4894, 2006
26. Neave LM, Mason BH, Kay RG: Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat 15:103-108, 1990
27. Porta M, Gallén M, Malats N, et al: Influence of "diagnostic delay" upon cancer survival: An analysis of five tumour sites. J Epidemiol Community Health 45:225-230, 1991
28. Richards MA, Smith P, Ramirez AJ, et al: The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858-864, 1999
29. Tartter PI, Pace D, Frost M, et al: Delay in diagnosis of breast cancer. Ann Surg 229:91-96, 1999
30. Vujovic O, Yu E, Cherian A, et al: Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys 75:771-774, 2009
31. Wilkinson GS, Edgerton F, Wallace HJ Jr, et al: Delay, stage of disease and survival from breast cancer. J Chronic Dis 32:365-373, 1979
32. Feldman JG, Saunders M, Carter AC, et al: The effects of patient delay and symptoms other than a lump on survival in breast cancer. Cancer 51:1226-1229, 1983
33. Charlson ME: Delay in the treatment of carcinoma of the breast. Surg Gynecol Obstet 160:393-399, 1985
34. Vernon SW, Tilley BC, Neale AV, et al: Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 55:1563-1571, 1985
35. Huguley CM Jr, Brown RL, Greenberg RS, et al: Breast self-examination and survival from breast cancer. Cancer 62:1389-1396, 1988
36. Machiavelli M, Leone B, Romero A, et al: Relation between delay and survival in 596 patients with breast cancer. Oncology 46:78-82, 1989
37. Rossi S, Cinini C, Di Pietro C, et al: Diagnostic delay in breast cancer: Correlation with disease stage and prognosis. Tumori 76:559-562, 1990
38. Raabe NK, Fossaa SD: Primary invasive breast carcinoma in Oslo 1980-1989: Incidence and delay. Acta Oncol 35:9-15, 1996
39. Fisher ER, Redmond C, Fisher B: A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer 40:3160-3167, 1977
40. Anderson RT, Camacho, FT, Balkrishnan R, et al: Use of cancer registry data for research on patterns of breast cancer care of individuals with Medicaid insurance. J Clin Oncol 23:533s, 2005 (suppl; abstr 6021)
41. North Carolina Department of Health and Human Services: Medicaid in North Carolina: Annual Report, State Fiscal Year 2007. Raleigh, NC, North Carolina Division of Medical Assistance, 2008
42. Abrams JA, Buono DL, Strauss J, et al: Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly. Cancer 115:4924-4933, 2009
43. Office of Management and Budget: Measuring Rurality: New Definitions in 2003. Washington, DC, Executive Office of the President of the United States, 2003
44. Health Resources and Services Administration: HPSA by State and County. Bethesda, MD, US Department of Health and Human Services, 2010
45. D'Hoore W, Bouckaert A, Tilquin C: Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 49:1429-1433, 1996
46. Caplan LS, Helzlsouer KJ, Shapiro S, et al: Reasons for delay in breast cancer diagnosis. Prev Med 25:218-224, 1996
47. Caplan LS, May DS, Richardson LC: Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health 90:130-134, 2000
48. Gorin SS, Heck JE, Cheng B, et al: Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244-2252, 2006
49. Gwyn K, Bondy ML, Cohen DS, et al: Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595-1604, 2004
50. Lund MJ, Brawley OP, Ward KC, et al: Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat 109:545-557, 2008
51. Maly RC, Leake B, Silliman RA: Breast cancer treatment in older women: Impact of the patient-physician interaction. J Am Geriatr Soc 52:1138-1145, 2004
52. Ramirez AJ, Westcombe AM, Burgess CC, et al: Factors predicting delayed presentation of symptomatic breast cancer: A systematic review. Lancet 353:1127-1131, 1999
53. Mickey RM, Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129:125-137, 1989
54. Richardson LC, Royalty J, Howe W, et al: Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005. Am J Public Health 100:1769-1776, 2010
55. Ryerson AB, Benard VB, Major AC: The National Breast and Cervical Cancer Early Detection Report: 1991-2002, National Report. Atlanta, GA, Department of Health and Human Services, 2005
56. US Census Department: 2010 USA Quick Facts. Washington, DC, US Department of Commerce, 2010
57. Altekruse SF, Kosary CL, Krapcho M, et al (eds): SEER cancer statistics review, 1975-2007, National Cancer Institute. http://seer.cancer.gov/csr/1975- 2007/